在HCC检测方面,HES V2.0超过了GALAD:对多维生物标志物评分和研究的审查
Fouad Jaber1, Hashem B El-Serag1
1Department of Internal Medicine, Section of Gastroenterology and Hepatology, Baylor College of Medicine, Houston, Texas, USA.
Hepatic oncology
|May 1, 2025
概括
多维生物标记得分提高了肝细胞癌 (HCC) 的检测. 新的HCC早期检测查 (HES) V2.0显示,与其他评分相比,早期HCC的灵敏度更高.
科学领域:
- 生物标志物研究 生物标志物研究
- 肝细胞癌 (HCC) 检测检测
- 瘤发生的发生因子.
背景情况:
- 单个生物标志物方法在准确检测肝细胞癌 (HCC) 中存在局限性.
- 多维生物标志物得分整合了各种临床和生化因素,以提高预测准确度.
- 生物标志物研究的进步对于早期HCC检测和管理至关重要.
研究的目的:
- 审查转向用于检测HCC的多维生物标志物得分的转变.
- 在第三阶段研究中比较不同生物标志物得分的性能.
- 评估HES V2.0作为早期HCC检测的主要候选者的潜力.
主要方法:
- 通过2024年9月发表的精选研究的叙述性综述.
- 分析多维生物标记得分,包括HES,GALAD,ASAP和mt-HBT.
- 在第三阶段研究中的生物标志物得分的比较性能的评估.
主要成果:
- 肝细胞癌早期检测查 (HES) V2.0在检测早期HCC时优于GALAD和ASAP.
- 在90%的特异性下,HES V2.0显示了比GALAD更高的6.7%灵敏度和比ASAP更高的13.4%-18.0%灵敏度.
- HES V2.0评分整合了多个生物标志物 (AFP,AFP L3,DCP) 和临床因素,以提高准确性.
结论:
- 多维生物标记得分代表了HCC检测的重大进步.
- 在临床研究中,HES V2.0是一个有前途的生物标志物评分,用于前性测试.
- 在广泛采用之前,在第三阶段研究中对生物标志物评分的适当验证至关重要.
相关概念视频
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...